141.35
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Biogen (BIIB) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Why Biogen Inc. (BIIB) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance
Biogen Inc. (NASDAQ:BIIB) Stake Boosted by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Greenleaf Trust Has $775,000 Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Win Advisors Inc. Buys New Shares in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen (BIIB) to Release Earnings on Tuesday - MarketBeat
12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey
As US Sales of Leqembi Lag, Eisai Eyes SubQ Approvals - BioSpace
Seeking Clues to Biogen (BIIB) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
IMMINENT BIIB DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit - ACCESS Newswire
Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FY2024 EPS Estimates for Biogen Reduced by Cantor Fitzgerald - MarketBeat
Retirement Systems of Alabama Purchases 154,062 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug - MSN
Cantor Fitzgerald cuts Biogen stock price target to $206 By Investing.com - Investing.com South Africa
Cantor Fitzgerald cuts Biogen stock price target to $206 - Investing.com
Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Old North State Wealth Management LLC - MarketBeat
abrdn plc Reduces Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Judge Explains Biogen Class Cert. Ruling After 1st Circ. Order - Law360
Global Water Flavouring Drops Market Poised for Substantial Growth, Projected to Reach USD 73.91 Billion by 2035 | Future Market Insights, Inc. - GlobeNewswire Inc.
Biogen Inc. (NASDAQ:BIIB) Shares Sold by China Universal Asset Management Co. Ltd. - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Forsta AP Fonden - MarketBeat
FY2025 EPS Estimates for Biogen Lowered by Leerink Partnrs - MarketBeat
Sumitomo Life Insurance Co. Trims Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Cairn Investment Group Inc. Sells 3,153 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
One week after Netherlands defeat Biogen takes the win in Germany - JUVE Patent
BRIEF—EC calls for update on regulatory review of lecanemab - The Pharma Letter
Robeco Institutional Asset Management B.V. Has $62.43 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Tardive Dyskinesia Treatment Market Report Analysis - openPR
(BIIB) Investment Analysis and Advice - Stock Traders Daily
FY2027 EPS Estimates for Biogen Reduced by Leerink Partnrs - MarketBeat
Why Are Analysts Bullish on Biogen Inc. (BIIB) Now? - MSN
Smith Group Asset Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
12 Best S&P 500 Stocks to Invest in According to Analysts - Insider Monkey
Kirr Marbach & Co. LLC IN Sells 4,578 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Citigroup Has Lowered Expectations for Biogen (NASDAQ:BIIB) Stock Price - MarketBeat
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union - GlobeNewswire
Biogen Inc. stock underperforms Friday when compared to competitors - MarketWatch
Leqembi review stalls again at European regulator - BioWorld Online
Biogen Stock Price | BIIB Stock Quote, News, and History - Markets Insider
Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok - Benzinga
Europe to review safety data for Eisai-Biogen Alzheimer's drug - Reuters
Biogen, Eisai Say EU Panel Set to Discuss Additional Safety Data on Lecanemab -January 31, 2025 at 08:10 am EST - Marketscreener.com
EU to Weigh New Safety Data on Biogen, Eisai Alzheimer’s Drug - Bloomberg
Europe to review safety data for Eisai-Biogen Alzheimer’s drug - 1470 & 100.3 WMBD
Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi - MarketWatch
Biogen stock in focus as Alzheimer’s drug review delayed (BIIB) - Seeking Alpha
Europe to review safety data for Eisai-Biogen Alzheimer's drug -January 31, 2025 at 07:05 am EST - Marketscreener.com
Rx Rundown: Merck, Biogen, Pfizer and more - MM+M Online
European Commission Demands Fresh Safety Analysis of Breakthrough Alzheimer's Treatment - StockTitan
Amyotrophic Lateral Sclerosis (ALS) Market Future Prospects, - openPR
March 14th Options Now Available For Biogen (BIIB) - Nasdaq
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):